Stallion Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 2.53 Cr
- Company Age 37 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 64.87 Cr
- Satisfied Charges ₹ 1.65 Cr
- Revenue Growth 16.29%
- Profit Growth 20.87%
- Ebitda 7.62%
- Net Worth 24.61%
- Total Assets 10.20%
About Stallion Laboratories
Stallion Laboratories Pvt Ltd (SLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 January 1988 and has a history of 37 years. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.53 Cr.
The company currently has active open charges totaling ₹64.87 Cr. The company has closed loans amounting to ₹1.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vipulkumar Shah, Vijay Shah, and Arvindkumar Thakker serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1988PTC010285
-
Company No.
010285
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jan 1988
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Stallion Laboratories Pvt Ltd offer?
Stallion Laboratories Pvt Ltd offers a wide range of products and services, including Inspection & Quality Check Services, Quality Inspection Service, Anti Inflammatory Drugs, Methylprednisolone Tablet, Business Planning and Management, Business Consultant, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Health Conditions, Cold & Cough.
Who are the key members and board of directors at Stallion Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Shah
|
Director | 30-May-1990 | Current |
|
Vipulkumar Shah
|
Director | 30-May-1990 | Current |
|
Arvindkumar Thakker
|
Director | 25-Jun-2020 | Current |
Financial Performance of Stallion Laboratories.
Stallion Laboratories Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 16.29% increase. The company also saw a substantial improvement in profitability, with a 20.87% increase in profit. The company's net worth Soared by an impressive increase of 24.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stallion Laboratories?
In 2023, Stallion Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Endurance Healthcare Private LimitedVijay Shah is a mutual person
-
Gnana Life Sciences Private LimitedVijay Shah is a mutual person
Charges (Loans)
₹64.87 Cr
₹1.65 Cr
Charges Breakdown by Lending Institutions
- Others : 32.89 Cr
- State Bank Of India : 15.77 Cr
- Bank Of Baroda : 14.59 Cr
- Hdfc Bank Limited : 1.62 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jan 2024 | Hdfc Bank Limited | ₹1.40 M | Open |
| 02 Aug 2023 | Hdfc Bank Limited | ₹5.01 M | Open |
| 17 Jun 2023 | Others | ₹1.30 M | Open |
| 27 Sep 2022 | Hdfc Bank Limited | ₹9.79 M | Open |
| 30 Mar 2022 | Others | ₹1.00 M | Open |
How Many Employees Work at Stallion Laboratories?
Stallion Laboratories has a workforce of 136 employees as of Nov 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stallion Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stallion Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
